Navigation Links
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Date:11/15/2010

lferminogene tadenovec, Ad5FGF-4) is a DNA-based angiogenic growth factor therapeutic product candidate representing a new class of cardiovascular biologics as a treatment for patients with advanced coronary artery disease.  Generx is designed to stimulate and promote the growth of collateral vessels to enhance myocardial blood flow (perfusion) following a one-time intracoronary administration from a standard cardiac infusion catheter in patients who have insufficient blood flow due to atherosclerotic plaque build-up in the coronary arteries.  Generx has progressed through four randomized, placebo controlled clinical studies at over 100 medical centers in the United States and Western Europe that have enrolled over 650 patients.

In June 2010, Cardium announced that it had entered into a Master Services Agreement with bioRASI, an international contract research organization, to assist in the conduct of a late-stage clinical study (ASPIRE) designed to support regulatory approval and commercialization activities for Generx in Russia and affiliated jurisdictions, as well as in other newly industrializing markets.  The Generx clinical study will be conducted at three leading medical centers in Moscow and will be a randomized, controlled, parallel-group, multi-center study to evaluate the safety and efficacy of Generx using SPECT imaging of myocardial blood flow in patients with stable angina pectoris.  The primary endpoint will be the change in reversible perfusion defect size as measured by SPECT imaging, which is directly analogous to that successfully used in a Phase 2a clinical study of Generx in the United States.  

Positive results from the prior Phase 2a clinical study (Grines et al., J Am Coll Cardiol 2003; 42:1339-47) showed that Generx improved myocardial blood flow in the ischemic region of the hearts of men and women following a single intracoronary infusion as measured by the objective efficacy endpoint o
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Aware, Inc. Reports Third Quarter 2010 Financial Results
2. Smithsonian reports regional sea temperature rise and coral bleaching event in Western Caribbean
3. Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
4. Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
5. GEN reports on the greening of the life sciences
6. Aware, Inc. Reports Second Quarter 2010 Financial Results
7. GEN reports on rediscovered technology to bolster proteomics research
8. BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results
9. International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit
10. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
11. New climate change reports underscore need for action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the ... Security Systems Market" report to their offering. ... perimeter security market is estimated to grow at a CAGR ... holds a larger share in this market, Canada ...
(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is insourcing its ... counterfeit microcircuits from entering into its supply chain. ... anti-counterfeit initiative dubbed DNA marking. The capability will validate ... throughout the supply chain. The new quality control measures ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... A Cornell University study offers further proof that the ... million years ago was profoundly influenced by mutations to DNA ... The study, published June 9 in Nature Genetics ... genes must play an important role in evolution since there ...
... of scientific, technical and medical information products and services, is ... journal, GeoResJ . With the launch of ... has its first open access only journal. The journal aims ... within the entire earth science field. The journal will be ...
... Department,s National Renewable Energy Laboratory (NREL), and the University ... novel cellulose-degrading enzyme from a marine wood borer ... Gribbles are biologically intriguing because they exhibit a ... of using symbiotic microbes to break down the biomass ...
Cached Biology News:New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Novel enzyme from tiny gribble could prove a boon for biofuels research 2
(Date:1/22/2015)... Boston, MA (PRWEB) January 22, 2015 ... systems, is pleased to announce an exciting product from a ... of motion analysis solutions over the past 15 years, with ... industries. Most recently, their 3D IMU system (inertial measurement unit), ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Controlled Substance ... Alliance, which helps companies check the legal requirements around ... expand to China. , As their international operations ... globally adopting software solutions built as a result of ...
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
(Date:1/22/2015)...   Cypher Genomics, Inc., the leading genome ... SQNM ), the leading molecular diagnostics company, today ... prenatal tests (NIPT). Through this agreement, Sequenom will ... advance analysis of clinically-relevant fetal sub-chromosomal variants detected ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... LOS ALTOS, Calif. , July 19 ... vitro fertilization (IVF) prognostic tools, announced today the publication ... the National Academy of Sciences ( PNAS ) by ... University .  The peer-reviewed paper details their development of the ...
... , July 19 Reportlinker.com announces that a new market research report is available in its catalogue: ... China In Vitro Diagnostics Market Outlook to 2016 , , ... , , China In ... Summary , , ...
... , July 19 Reportlinker.com announces that a new market research report is available in ... Stem Cells Market And Applications. 2009-2015 , ... http://www.reportlinker.com/p0239912/Stem-Cells-Market-And-Applications-2009-2015.html , , , ... , The ,Stem Cells Market and ...
Cached Biology Technology:Univfy and Stanford Scientists Develop the First Personalized Prognostic Test to Predict Live Birth Outcomes with In Vitro Fertilization 2Univfy and Stanford Scientists Develop the First Personalized Prognostic Test to Predict Live Birth Outcomes with In Vitro Fertilization 3Univfy and Stanford Scientists Develop the First Personalized Prognostic Test to Predict Live Birth Outcomes with In Vitro Fertilization 4Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 2Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 3Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 4Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 5Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 6Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 7Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 8Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 9Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 10Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 11Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 12Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 13Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 14Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 15Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 16Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 17Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 18Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 19Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 20Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 21Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 22Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 23Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 24Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 25Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 26Reportlinker Adds Stem Cells Market And Applications. 2009-2015 2Reportlinker Adds Stem Cells Market And Applications. 2009-2015 3Reportlinker Adds Stem Cells Market And Applications. 2009-2015 4Reportlinker Adds Stem Cells Market And Applications. 2009-2015 5Reportlinker Adds Stem Cells Market And Applications. 2009-2015 6Reportlinker Adds Stem Cells Market And Applications. 2009-2015 7Reportlinker Adds Stem Cells Market And Applications. 2009-2015 8
oligophrenin-1 (H-100)...
... Strong reactivity with rat (100%), ... guinea pig (48%). Slight ... Specificity confirmed by Western blot ... rat Gia-1, Gia-2, rat Gia-3, ...
KOR-1 (C-20)...
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Biology Products: